D-Index & Metrics Best Publications
Guillaume Lessene

Guillaume Lessene

Walter and Eliza Hall Institute of Medical Research
Australia

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Organic chemistry
  • Cancer

His main research concerns Cancer, Programmed cell death, Apoptosis, Cancer research and Pharmacology. His Cancer study combines topics in areas such as Myeloid Cell Leukemia Sequence 1 Protein, Bcl-2 Homologous Antagonist-Killer Protein and Oncology. His Programmed cell death study frequently draws connections between related disciplines such as Cell biology.

His biological study spans a wide range of topics, including Protein structure and Intrinsic apoptosis. Guillaume Lessene has researched Cancer research in several fields, including Venetoclax and Protein family. His Pharmacology research includes themes of Bcl-xL and Leukemia.

His most cited work include:

  • Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy (1632 citations)
  • The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models (499 citations)
  • The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models (499 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cancer research, Programmed cell death, Apoptosis, Cell biology and Cancer. The concepts of his Cancer research study are interwoven with issues in Hematology, Internal medicine, Venetoclax, Bcl-xL and MCL1. He works in the field of Programmed cell death, focusing on Intrinsic apoptosis in particular.

His Apoptosis study also includes fields such as

  • Plasma protein binding which connect with Binding site,

  • In vitro that connect with fields like Colorectal cancer. His Cell biology research is multidisciplinary, incorporating elements of Bcl-2 Homologous Antagonist-Killer Protein and Necroptosis. His Cancer study also includes

  • BH3 Mimetic ABT-737 most often made with reference to Pharmacology,

  • Stereochemistry which intersects with area such as Combinatorial chemistry.

He most often published in these fields:

  • Cancer research (56.33%)
  • Programmed cell death (41.77%)
  • Apoptosis (39.24%)

What were the highlights of his more recent work (between 2019-2021)?

  • Cancer research (56.33%)
  • Venetoclax (23.42%)
  • Bcl-xL (32.28%)

In recent papers he was focusing on the following fields of study:

Guillaume Lessene mainly focuses on Cancer research, Venetoclax, Bcl-xL, Small molecule and Programmed cell death. Guillaume Lessene has included themes like Cytotoxic T cell, In vitro, Mitosis, Cell division and Colorectal cancer in his Cancer research study. His Venetoclax research includes elements of Hematology, MCL1 and Bh3 mimetics.

Bcl-xL is a subfield of Apoptosis that he explores. His research integrates issues of Ovarian cancer, Neuroblastoma and Phosphorylation in his study of Programmed cell death. His RIPK1 research integrates issues from Serine, Protein kinase A, Photoaffinity labeling and Effector, Cell biology.

Between 2019 and 2021, his most popular works were:

  • Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. (54 citations)
  • Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2. (54 citations)
  • MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis (32 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Organic chemistry
  • Cancer

His primary areas of study are Cell biology, Binding site, Protease, Ubiquitin and ISG15. His Cell biology study combines topics from a wide range of disciplines, such as Programmed cell death, RIPK1 and Necroptosis. His Programmed cell death research is multidisciplinary, relying on both Transport protein, Cell junction, Cell membrane, Tight junction and Effector.

His Necroptosis study integrates concerns from other disciplines, such as Photoaffinity labeling, Serine and Protein kinase A. Guillaume Lessene has included themes like Protein structure, Innate immune system and Viral replication in his Binding site study. His Protease research encompasses a variety of disciplines, including Small molecule, Biochemistry, Papain and Proteases.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

Peter E Czabotar;Guillaume Lessene;Andreas Strasser;Jerry M Adams.
Nature Reviews Molecular Cell Biology (2014)

2796 Citations

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy;Zoltán Szlavik;James Murray;James Davidson.
Nature (2016)

805 Citations

BCL-2 family antagonists for cancer therapy

Guillaume Lessene;Peter E. Czabotar;Peter M. Colman.
Nature Reviews Drug Discovery (2008)

682 Citations

Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production

Michael J. White;Michael J. White;Kate McArthur;Kate McArthur;Donald Metcalf;Donald Metcalf;Rachael M. Lane.
Cell (2014)

599 Citations

Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death

Joanne M. Hildebrand;Maria C. Tanzer;Isabelle S. Lucet;Isabelle S. Lucet;Samuel N. Young.
Proceedings of the National Academy of Sciences of the United States of America (2014)

445 Citations

BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis

Kate McArthur;Kate McArthur;Kate McArthur;Lachlan W. Whitehead;Lachlan W. Whitehead;John M. Heddleston;Lucy Li.
Science (2018)

420 Citations

Structure-guided design of a selective BCL-XL inhibitor

Guillaume Lessene;Guillaume Lessene;Peter Edward Czabotar;Peter Edward Czabotar;Brad Sleebs;Brad Sleebs;Kerry Zobel.
Nature Chemical Biology (2013)

381 Citations

Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.

Theresa Klemm;Gregor Ebert;Dale J Calleja;Cody C Allison.
The EMBO Journal (2020)

224 Citations

Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity

Zhi-Fu Tao;Lisa Hasvold;Le Wang;Xilu Wang.
ACS Medicinal Chemistry Letters (2014)

200 Citations

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.

Delphine Merino;Gemma L. Kelly;Guillaume Lessene;Andrew H. Wei.
Cancer Cell (2018)

190 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Guillaume Lessene

James M. Murphy

James M. Murphy

Walter and Eliza Hall Institute of Medical Research

Publications: 121

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 115

David C. S. Huang

David C. S. Huang

Walter and Eliza Hall Institute of Medical Research

Publications: 67

John Silke

John Silke

Walter and Eliza Hall Institute of Medical Research

Publications: 61

Marco J. Herold

Marco J. Herold

Walter and Eliza Hall Institute of Medical Research

Publications: 59

Peter E. Czabotar

Peter E. Czabotar

Walter and Eliza Hall Institute of Medical Research

Publications: 56

James E. Vince

James E. Vince

Walter and Eliza Hall Institute of Medical Research

Publications: 47

Ana J. García-Sáez

Ana J. García-Sáez

University of Cologne

Publications: 45

Grant Dewson

Grant Dewson

Walter and Eliza Hall Institute of Medical Research

Publications: 43

Anthony Letai

Anthony Letai

Harvard University

Publications: 35

Andrew W. Roberts

Andrew W. Roberts

Walter and Eliza Hall Institute of Medical Research

Publications: 35

Simone Fulda

Simone Fulda

Goethe University Frankfurt

Publications: 33

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 29

Boris Zhivotovsky

Boris Zhivotovsky

Karolinska Institute

Publications: 28

David L. Vaux

David L. Vaux

Walter and Eliza Hall Institute of Medical Research

Publications: 28

Ruth M. Kluck

Ruth M. Kluck

Walter and Eliza Hall Institute of Medical Research

Publications: 27

Trending Scientists

Jacques-Louis Lions

Jacques-Louis Lions

Collège de France

Lu Yuan

Lu Yuan

Microsoft (United States)

Akshay Kumar Rathore

Akshay Kumar Rathore

Concordia University

Teresa Wu

Teresa Wu

Arizona State University

Changkook Ryu

Changkook Ryu

Sungkyunkwan University

P. J. Hore

P. J. Hore

University of Oxford

Edgar D. Zanotto

Edgar D. Zanotto

Federal University of São Carlos

Litong Zhang

Litong Zhang

Northwestern Polytechnical University

Isabelle Martin-Verstraete

Isabelle Martin-Verstraete

Université Paris Cité

Lars-Anders Hansson

Lars-Anders Hansson

Lund University

Corey Largman

Corey Largman

University of California, San Francisco

Baek Kim

Baek Kim

Emory University

Ryota Hino

Ryota Hino

Tohoku University

Yasushi Yamaguchi

Yasushi Yamaguchi

Nagoya University

Christian G. Bien

Christian G. Bien

Bielefeld University

Nobuoki Kohno

Nobuoki Kohno

Hiroshima University

Something went wrong. Please try again later.